- Q1 2024 Icade SA Earnings Call TranscriptApr 22, 2024$27Earnings
- Q3 2023 Icade SA Earnings Call TranscriptOct 23, 2023$30.01Earnings
- Half Year 2023 Icade SA Earnings Call TranscriptJul 24, 2023$37.7Earnings
- Q1 2023 Icade SA Earnings Call TranscriptApr 24, 2023$47.14Earnings
- Icade SA Corporate Call TranscriptMar 14, 2023
- Full Year 2022 Icade SA Earnings Call TranscriptFeb 20, 2023Earnings
- Icade SA Investor Day 2022 TranscriptNov 28, 2022
- Q3 2022 Icade SA Earnings Call TranscriptOct 24, 2022$35.5Earnings
- Half Year 2022 Icade SA Earnings Call TranscriptJul 25, 2022$48Earnings
- Q1 2022 Icade SA Corporate Sales Call TranscriptApr 25, 2022
- Full Year 2021 Icade SA Earnings Call TranscriptFeb 21, 2022Earnings
- Icade SA Investor Day TranscriptNov 29, 2021
- Q3 2021 Icade SA Corporate Sales Call TranscriptOct 25, 2021
- Half Year 2021 Icade SA Earnings Call TranscriptJul 26, 2021$88.18Earnings
- Q1 2021 Icade SA Corporate Sales Call TranscriptApr 26, 2021
- Full Year 2020 Icade SA Earnings Presentation TranscriptFeb 22, 2021
- Icade SA Investor Day TranscriptNov 23, 2020
- Q3 2020 Icade SA Corporate Sales Call TranscriptOct 22, 2020
- Half Year 2020 Icade SA Earnings Call TranscriptJul 21, 2020$66.67Earnings
- Full Year 2019 Icade SA Earnings Call TranscriptFeb 17, 2020Earnings
- Icade SA Investor Day TranscriptNov 25, 2019
- Half Year 2019 Icade SA Earnings Call TranscriptJul 22, 2019$83.75Earnings
- Full Year 2018 Icade SA Earnings Call (English, French) TranscriptFeb 18, 2019Earnings
Icade SA Corporate Call Transcript
Hello, and welcome to today's Icade conference call. Please note that this conference is being recorded (Operator Instructions) I will now hand over to your host, Olivier Wigniolle, CEO; and Victoire Aubry, CFO, to begin today's call.
Thank you. So good morning, everyone. So I'm Olivier Wigniolle speaking, and I am with Victoire Aubry and also (inaudible). We have organized this call just to present the transaction that occurred yesterday because yesterday, we have signed an exclusivity agreement with Primonial in order to sell our stake in Icade Santé.
So as you could see, I am on Slide 2 of the presentation. Maybe to start with, and just to remind you some figures about our stake in healthcare real estate. In terms of value, in terms of NAV value at the end of last year, it represents a value of EUR 2.6 billion based on the NTA NAV, which [were it's] peak in 2 parts, EUR 2.3 billion for Icade Santé and EUR 0.3 billion for Icade Healthcare Europe, which is more the international portfolio. And just also to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)